Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Article

January 1, 2004

Sweeping changes

Author(s):

Washington, D.C. - With a handful of new options expected to receive FDA approval within a year, the field of tissue augmentation stands poised to undergo a seismic shift. "The bottom line is, tissue augmentation is about to change dramatically," said Mariano E. Busso, M.D. He is clinical professor in the University of Miami's department of dermatology, chief of dermatology at Mercy Hospital, also in Miami, Fla., and a private practitioner who is board-certified in dermatology.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!